SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-022093
Filing Date
2023-06-14
Accepted
2023-06-14 17:03:30
Documents
1
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686776597.html 4  
1 FORM 4 wk-form4_1686776597.xml 4 3540
  Complete submission text file 0001628280-23-022093.txt   5001
Mailing Address 33 PHEASANT LANE GREENWICH CT 06830
Business Address
MCGIRR DAVID W J (Reporting) CIK: 0001219023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 231014891

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)